Clinical trial
A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT00479336 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- January 31, 2009
- Enrollment
- 104 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis